An in-depth look to GENEFERM BIOTECHNOLOGY CO LTD operating, investing, and financing activities

1796 free cash flow for Q3 24 is -38.44 M TWD. For 2023, 1796 free cash flow was 134.88 M TWD and operating cash flow was 204.82 M TWD.